Lawrence Boxt

SCCT guidelines for the interpretation and reporting of coronary computed tomographic angiography

The increasing use of coronary computed tomographyangiography(CCTA)requirestheestablishmentofstandardsmeant to ensure reliable practice methods and qualityoutcomes.TheSocietyofCardiovascularComputedTomog-raphy Guidelines Committeewas formed to develop recom-mendations for acquiring, interpreting, and reporting thesestudies in a standardized fashion. Indications and contrain-dicationsforspecificservicesorproceduresarenotincludedin the scope of these documents. These recommendationswere produced as an educational tool for practitioners toimprove the diagnostic care of patients, in the interest ofdevelopingsystematicstandardsofpracticeforCCTAbasedon the best available data or broad expert consensus. Due tothe highly variable nature of individual medical cases, anapproachtointerpretationorreportingthatdiffersfromtheseguidelinesmayrepresentanappropriatevariationbasedonalegitimate assessment of an individual patient’s needs.The Society of Cardiovascular Computed TomographyGuidelinesCommitteemakeseveryefforttoavoidanyactualorpotentialconflictsofinterestthatmightariseasaresultofan outside relationship or a personal interest of a member ofthe Guidelines Committee or either of its Writing Groups.Specifically, all members of the Guidelines Committee andof both Writing Groups are asked to provide disclosurestatementsofallsuchrelationshipsthatmightbeperceivedasrealorpotentialconflictsofinterestrelevanttothedocumenttopic. The relationships with industry information for Com-mittee members and Writing Group members are published

Magnetic resonance and computed tomographic evaluation of congenital heart disease

Magnetic resonance imaging (MRI) and contrast‐enhanced computed tomography (CT) provide noninvasive visualization of morphologic changes in pediatric and adult patients with congenital heart disease, as well as the functional changes caused by the underlying morphologic abnormalities. Clinical experience with MRI is richer than that with fast CT, but CT appears to provide accurate and high‐quality imagery for diagnosis. The two modalities may be complementary. That is, intracardiac anatomy is so well depicted by MRI, and CT provides exquisite images of the great vessels. Furthermore, in adult patients, MR and CT are helpful in demonstrating and quantitating physiologic changes superimposed by acquired cardiovascular disease on the underlying congenital malformations. Using MRI, spin echo acquisitions provide the image data for evaluation of morphologic changes, and gradient reversal techniques add functional and flow data to complement morphologic changes. Contrast‐enhanced electrocardiographic (ECG)‐gated multidetector and electron beam CT examination provide morphologic information and may be used as a data set for off‐line functional quantitation. J. Magn. Reson. Imaging 2004;19:827–847.

Brain and high metabolic rate organ mass: contributions to resting energy expenditure beyond fat-free mass

BACKGROUND The degree to which interindividual variation in the mass of select high metabolic rate organs (HMROs) mediates variability in resting energy expenditure (REE) is unknown. OBJECTIVE The objective was to investigate how much REE variability is explained by differences in HMRO mass in adults and whether age, sex, and race independently predict REE after adjustment for HMRO. DESIGN A cross-sectional evaluation of 55 women [30 African Americans aged 48.7 +/- 22.2 y (mean +/- SD) and 25 whites aged 46.4 +/- 17.7 y] and 32 men (8 African Americans aged 34.3 +/- 18.2 y and 24 whites aged 51.3 +/- 20.6 y) was conducted. Liver, kidney, spleen, heart, and brain masses were measured by magnetic resonance imaging, and fat and fat-free mass (FFM) were measured by dual-energy X-ray absorptiometry. REE was measured by indirect calorimetry. RESULTS REE estimated from age (P = 0.001), race (P = 0.006), sex (P = 0.31), fat (P = 0.001), and FFM (P < 0.001) accounted for 70% (adjusted (2)) of the variability in REE. The addition of trunk HMRO (P = 0.001) and brain (P = 0.006) to the model increased the explained variance to 75% and rendered the contributions of age, sex, and race statistically nonsignificant, whereas fat and FFM continued to make significant contributions (both P < 0.05). The addition of brain to the model rendered the intercept (69 kcal . kg(-1) . d(-1)) consistent with zero, which indicated zero REE for zero body mass. CONCLUSIONS Relatively small interindividual variation in HMRO mass significantly affects REE and reduces the role of age, race, and sex in explaining REE. Decreases in REE with increasing age may be partly related to age-associated changes in the relative size of FFM components.

RADIOLOGY OF THE RIGHT VENTRICLE

RV changes may be generalized into dilatation and hypertrophy. Increased preload results in ventricular dilatation. Increased afterload causes hypertrophy. Change in the shape of the RV resulting from increased afterload and myocardial hypertrophy induces tricuspid regurgitation, which superimposes changes of chamber dilatation onto those of hypertrophy. Sustained ventricular dilatation and hypertrophy frequently progresses to RV failure. In these cases, RV systolic function decreases in association with elevation of RV and right atrial diastolic pressure. Changes in the wall thickness and shape of the RV are variable, and depend upon the severity of the volume or pressure load presented, as well as its duration and rate of progression. Because the RV is an anterior cardiac structure, it occupies little of any heart border. Therefore, the sensitivity of plain film examination to RV disease is limited. Inferential diagnosis of RV disease can often be made based upon identification of other radiographic changes, notably the state of the pulmonary circulation, and the position of the heart in the chest. Conventional contrast right ventriculography may be used to assess the size and position of the RV, as well as associated acquired and congenital lesions that result in RV dysfunction. Due to the unusual shape of the RV cavity, however, and the unpredictable manner in which it dilates, accurate quantitative analysis by this technique is limited. Furthermore, the common association between RV disease and pulmonary hypertension limits the applicability of this imaging technique for evaluating patients with RV disease. Multiplanar MR imaging allows direct demonstration of changes in RV size and wall morphology. Furthermore, application of Simpsons rule to tomographic slices acquired at ventricular diastole and systole allows direct, accurate, and reproducible quantitative analysis of ventricular volume and myocardial mass, allowing radiographic assessment in patients for diagnosis, as well as longitudinally during medical management or after surgical treatment for congenital and acquired diseases that result in RV dysfunction.

Computed tomography for assessment of cardiac chambers, valves, myocardium and pericardium

The focus to date of MDCT has been primarily on CT applications for evaluating the coronary arteries, notably the measurement of coronary artery calcification, plaque characterization, and atherosclerotic lumen stenosis. This is because of the limited temporal resolution of CT, and the recent rapid improvements in MRI for cardiac applications. However, if the temporal resolution of MDCT can be improved, there will be a compelling argument for undertaking further CT validation studies. Feasibility of CT has already been established by EBT for general cardiac diagnosis. Modifications for MDCT include improved software methods for post processing ECG-gated scan data or higher speed CT hardware for faster image acquisition, both of which are being developed at this time. EBT is also evolving and continuously being refined so that the new generation of scanners have exposure times of 50 msec or less. There are many considerations in comparing the pros and cons of competing cardiac imaging modalities. Published diagnostic validations studies, convenience, procedure time, the comfort level (of patients and physicians), availability, and cost are all critical. The level of acceptance and the accuracy with which specific patient management questions can be appropriately answered are crucial issues in determining which diagnostic procedure to perform. However, the jury is still out regarding the ultimate role of CT in the diagnosis of heart disease; certainly the great potential of cardiac CT has not yet been fully realized.

Smaller organ mass with greater age, except for heart

Autopsy/cadaver data indicate that many organs and tissues are smaller in the elderly compared with young adults; however, in vivo data are lacking. The aim of this study was to determine whether the mass of specific high-metabolic-rate organs is different with increasing age, using MRI. Seventy-five healthy women (41 African-Americans and 34 Caucasians, age range 19-88 yr) and 36 men (8 African-Americans and 28 Caucasians, age range 19-84 yr) were studied. MRI-derived in vivo measures of brain, heart, kidneys, liver, and spleen were acquired. Left ventricular mass (LVM) was measured by either echocardiography or cardiac gated MRI. Total body fat mass and fat-free mass (FFM) were measured with a whole body dual-energy X-ray absorptiometry (DXA) scanner. Multiple regression analysis was used to investigate the association between the organ mass and age after adjustment for weight and height (or DXA measures of FFM), race, sex, and interactions among these variable. No statistically significant interaction was found among age, sex, and race in any regression model. Significant negative relationships between organ mass and age were found for brain (P < 0.0001), kidneys (P = 0.01), liver (P = 0.001), and spleen (P < 0.0001). A positive relationship between LVM and age was found after adjustment for FFM (P = 0.037). These findings demonstrate that age has a significant effect on brain, kidneys, liver, spleen, and heart mass. The age effect was independent of race and sex.

Skeletal muscle and organ masses differ in overweight adults with type 2 diabetes

Whether lean body mass (LBM) composition, especially skeletal muscle and abdominal organs, differs in adults with type 2 diabetes (T2DM) compared with nondiabetic healthy controls has not been investigated. A subset of African-American and Caucasian participants with T2DM from the Look AHEAD (Action for Health in Diabetes) trial had body composition assessed and compared with a sample of healthy controls. Skeletal muscle mass (SMM), liver, kidneys, and spleen mass were quantified using a contiguous slice magnetic resonance imaging (MRI) protocol. Cardiac mass was quantified by either a cardiac gated MRI protocol or by echocardiography. MRI volumes were converted to mass using assumed densities. Dual-energy X-ray absorptiometry assessed LBM. Using general linear models adjusted for height, weight, sex, age, race, and interactions of diabetes status with race or sex, persons with T2DM (n = 95) had less LBM (49.7 vs. 51.6 kg) and SMM (24.1 vs. 25.4 kg) and larger kidneys (0.40 vs. 0.36 kg) than controls (n = 76) (all P < 0.01). Caucasians with T2DM had larger livers (1.90 vs. 1.60 kg, P < 0.0001) and spleens (0.29 vs. 0.22 kg, P < 0.01), and T2DM men had less cardiac mass than controls (0.25 vs. 0.30 kg, P < 0.001). In this sample, T2DM is characterized by less relative skeletal muscle and cardiac mass in conjunction with larger kidneys, liver, and spleen. Further investigation is needed to establish the causes and metabolic consequences of these race- and sex-specific organ mass differences in T2DM.

Multi-Detector Coronary CT Imaging for the Identification of Coronary Artery Stenoses in a “Real-World” Population

Background Multi-detector computed tomography (CT) has emerged as a modality for the non-invasive assessment of coronary artery disease (CAD). Prior studies have selected patients for evaluation and have excluded many of the “real-world” patients commonly encountered in daily practice. We compared 64-detector-CT (64-CT) to conventional coronary angiography (CA) to investigate the accuracy of 64-CT in determining significant coronary stenoses in a “real-world” clinical population. Methods A total of 1,818 consecutive patients referred for 64-CT were evaluated. CT angiography was performed using the GE LightSpeed VCT (GE® Healthcare). Forty-one patients in whom 64-CT results prompted CA investigation were further evaluated, and results of the two diagnostic modalities were compared. Results A total of 164 coronary arteries and 410 coronary segments were evaluated in 41 patients (30 men, 11 women, age 39-85 years) who were identified by 64-CT to have significant coronary stenoses and who thereafter underwent CA. The overall per-vessel sensitivity, specificity, positive predictive value, negative predictive value, and accuracy at the 50% stenosis level were 86%, 84%, 65%, 95%, and 85%, respectively, and 77%, 93%, 61%, 97%, and 91%, respectively, in the per-segment analysis at the 50% stenosis level. Conclusion 64-CT is an accurate imaging tool that allows a non-invasive assessment of significant CAD with a high diagnostic accuracy in a “real-world” population of patients. The sensitivity and specificity that we noted are not as high as those in prior reports, but we evaluated a population of patients that is typically encountered in clinical practice and therefore see more “real-world” results.

Repaired Coarctation of the Aorta Imaged by 64-Detector Computed Tomography

![Figure][1] A 35-year-old man with a history of aortic coarctation (CoA) repair during childhood presented with the complaint of atypical chest pain. During childhood, he had undergone CoA repair with the placement of a conduit from the aortic arch just distal to the left subclavian artery (

Left Ventricular Metastasis from a Primary Pancreatobiliary Tumor

Metastatic disease to the heart is not uncommon. We describe a case of a man in his 60s with an unusual metastasis to the heart and detail its intracardiac location by means of cardiac computerized tomography (CCT) and transthoracic echocardiography. To our knowledge, this is the first report of a pancreatobiliary tumor metastasizing exclusively to the left ventricle (LV) of the heart.